Literature DB >> 30635325

Complete resolution of giant cell arteritis after tocilizumab monotherapy determined by positron emission tomography-CT.

Takahiko Akagi1, Shunichi Fujita1, Tomoyuki Mukai1, Yoshitaka Morita1.   

Abstract

Entities:  

Keywords:  immunological products and vaccines; vasculitis

Mesh：

Substances：

Year:  2019        PMID： 30635325      PMCID： PMC6340510          DOI： 10.1136/bcr-2018-228697

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


× No keyword cloud information.
  3 in total

1.  Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case series.

Authors:  Michael Seitz; Stephan Reichenbach; Harald M Bonel; Sabine Adler; Felix Wermelinger; Peter M Villiger
Journal:  Swiss Med Wkly       Date:  2011-01-17       Impact factor: 2.193

2.  Tocilizumab in glucocorticoid-naïve large-vessel vasculitis.

Authors:  G Pazzola; I Padovano; L Boiardi; A Versari; N Pipitone; M Catanoso; L Pulsatelli; R Meliconi; C Salvarani
Journal:  Clin Exp Rheumatol       Date:  2013-01-09       Impact factor: 4.473

3.  Trial of Tocilizumab in Giant-Cell Arteritis.

Authors:  John H Stone; Katie Tuckwell; Sophie Dimonaco; Micki Klearman; Martin Aringer; Daniel Blockmans; Elisabeth Brouwer; Maria C Cid; Bhaskar Dasgupta; Juergen Rech; Carlo Salvarani; Georg Schett; Hendrik Schulze-Koops; Robert Spiera; Sebastian H Unizony; Neil Collinson
Journal:  N Engl J Med       Date:  2017-07-27       Impact factor: 91.245
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.